Fundamental Analysis of EQUILLIUM INC(NASDAQ:EQ) stock

Fundamental Rating

Overall EQ gets a fundamental rating of 3 out of 10. We evaluated EQ against 588 industry peers in the Biotechnology industry. EQ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, EQ is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EQ has reported negative net income.

In the past year EQ has reported a negative cash flow from operations.

In the past 5 years EQ always reported negative net income.

EQ had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of EQ (-26.38%) is better than 75.94% of its industry peers.

The Return On Equity of EQ (-59.06%) is better than 62.12% of its industry peers.

		Industry Rank	Sector Rank
ROA	-26.38%
ROE	-59.06%
ROIC	N/A

ROA(3y)-50.57%

ROA(5y)-46.54%

ROE(3y)-104.42%

ROE(5y)-83.42%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

EQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EQ does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, EQ has more shares outstanding

EQ has more shares outstanding than it did 5 years ago.

There is no outstanding debt for EQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

EQ has an Altman-Z score of -3.60. This is a bad value and indicates that EQ is not financially healthy and even has some risk of bankruptcy.

EQ has a Altman-Z score (-3.60) which is in line with its industry peers.

EQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-3.6

ROIC/WACCN/A

WACC9.75%

2.3 Liquidity

A Current Ratio of 1.79 indicates that EQ should not have too much problems paying its short term obligations.

EQ has a worse Current ratio (1.79) than 78.16% of its industry peers.

EQ has a Quick Ratio of 1.79. This is a normal value and indicates that EQ is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.79, EQ is doing worse than 76.62% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.79
Quick Ratio	1.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.95%, which is quite impressive.

The Revenue has grown by 128.94% in the past year. This is a very strong growth!

EPS 1Y (TTM)66.95%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-187.5%

Revenue 1Y (TTM)128.94%

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2Q-41.55%

3.2 Future

EQ is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.71% yearly.

The Revenue is expected to grow by 21.27% on average over the next years. This is a very strong growth

EPS Next Y88.78%

EPS Next 2Y12.27%

EPS Next 3Y-28.32%

EPS Next 5Y-16.71%

Revenue Next Year14%

Revenue Next 2Y9.95%

Revenue Next 3Y-2%

Revenue Next 5Y21.27%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

EQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EQ. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

EQ's earnings are expected to decrease with -28.32% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y12.27%

EPS Next 3Y-28.32%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for EQ!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EQUILLIUM INC

NASDAQ:EQ (5/3/2024, 7:00:01 PM)

After market: 1.6601 -0.01 (-0.59%)

1.67

+0.11 (+7.05%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap58.87M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-26.38%
ROE	-59.06%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.71

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.79
Quick Ratio	1.79
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)66.95%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y88.78%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)128.94%

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

EQUILLIUM INC (EQ)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens